Author:
Nikhil K. G.,Jayakumar K. T.,Shiny P. J.,Ramya N. K.,Kumar J. S.
Abstract
Abstract
Background
The neutrophil to lymphocyte ratio (NLR) is a measure of systemic inflammation, whereas Heart type fatty acid protein (HFABP) is a cytosolic protein released early after acute coronary syndrome (ACS). The aim of this research study is to determine whether NLR and H-FAB are useful in predicting the prognosis in patients with ST segment elevation myocardial infarction (STEMI) 48 h after admission. This is a prospective observational study conducted on 97 patients who had been admitted to emergency room with ST-elevation myocardial infarction in their ECG in a tertiary care centre of south India. The neutrophil–lymphocyte ratio was measured at the time of admission, 24th hour and 48th hour, and then compared with the outcome. To determine their significance in the MI episode, troponin-I and H-FABP were also measured.
Results
A significant correlation was found in the final outcomes of patients and the NLR at the time of admission and at 48 h (p = 0.01). Additionally, a substantial correlation between NLR and various degrees of LV dysfunction was also observed (p = 0.01). H-FABP was found to be positive in all 97 of the patients examined, whereas Troponin-I was only found to be positive in 56.7%.
Conclusion
The study's findings, indicated strong correlations between NLR and LVEF, indicated that NLR might serve as an early predictor of cardiac events which could be either poor prognosis or higher mortality. This research found that H-FABP may serve as an early MI diagnostic marker.
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Boden H, Van der Hoeven BL, Karalis I, Schalij MJ, Jukema JW (2012) Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment. JIM 271:521–536
2. Nakatani D, Sakata Y, Suna S et al (2013) Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction. Circulation J. 77:439–446
3. Thygesen K, Alpert JS, Jaffe AS et al (2018) Fourth universal definition of myocardial infarction. Circulation 138:e618–e651
4. White HD, Steg PG, Szarek M et al (2019) Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial. Eur Heart J 40:2801–2809
5. Sharma DJ, Nath HJ, Batta A, Goala AK (2023) Neutrophil-to-lymphocyte ratio (NLR) useful as a cost-effective preliminary prognostic marker in ST-elevation myocardial infarction (STEMI): an observational study from a tertiary care hospital in Northeast India. Cureus 15(3):e36885